NRADDP

Across TCGA pan-cancer cohorts, NRADDP RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated NRADDP data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher NRADDP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NRADDP expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCS show a favorable association.

KIRC, HNSC, and UCS are the cancer types where NRADDP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.530	0.688	<.001	117	view →
HNSC	OS	Median	II,III,IV	0.799	0.687	<.001	83	view →
UCS	DFS	Median	II,III,IV	0.627	0.249	<.001	72	view →
UVM	OS	Median	All	0.762	0.421	<.001	63	view →
UCEC	DFS	Tertile	IV	0.782	0.292	.002	36	view →
ACC	DFS	Median	All	0.281	0.618	<.001	36	view →
PRAD	DFS	Median	All	0.832	0.928	<.001	26	view →
BLCA	DFS	Quartile	All	0.725	0.400	.002	22	view →
BRCA	DFS	Quartile	II,III,IV	0.831	0.912	.011	18	view →
COAD	OS	Quartile	II,III,IV	0.690	0.913	.003	15	view →
KIRP	DFS	Quartile	IV	0.712	0.407	.017	15	view →
SKCM	DFS	Median	IV	0.632	0.139	.005	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

NRADDP–KIRC (DFS)

Open the KIRC breakdown →